Logo Image
In Brief
Spotlight

J&J and Lilly both unveil IL-23 inhibitor efficacy in Crohn’s disease

After both receiving FDA approval in UC, J&J and Eli Lilly are racing for their IL-23 inhibitors to get the green light in Crohn’s disease.

Latest news

Bavarian eyes mpox vaccine label expansion to include toddlers, kickstarts Phase II trial

The registrational trial is expected to support the approval for Bavarian’s mpox/smallpox vaccine use in children between two and 11 years of age.

Moderna and MSD begin trial of mRNA-4157 and Keytruda combination for lung cancer

INTerpath-009 is a global, randomised, double-blind trial that will involve 680 participants.

UAE’s clinical trials space matures with experience from Covid-19

At the Outsourcing in Clinical Trials conference, Rohan Simon from the UAE CRO IROS, spoke about the region’s clinical trials landscape.

Shockwave Medical enrols all subjects in study of PCI to treat calcified lesions

Around 71% of the enrolling sites were led by female principal investigators.

US Border Protection warns pharma of risks with incorrect biologic importation

At the Outsourcing in Clinical Trials Conference, US government personnel advised attendees on the transport of biologics across borders.

Maze Therapeutics reports positive data from Phase I AKD treatment trial

MZE829 was found to be well tolerated in the randomised, first-in-human trial.